Speaker illustration

Doctor Ho Sik Shin

Kosin University School of Medicine, Busan (Korea (Republic of))

Member of:

European Society of Cardiology

Impact of real-world off-label dose of Apixaban on long-term clinical outcomes in patients with atrial fibrillation and chronic kidney disease

Event: ESC Congress 2024

Topic: Oral Anticoagulation

Session: Clinical decision-making about oral anticoagulant therapy in atrial fibrillation

Thumbnail